Top

Gepubliceerd in:

01-04-2015

Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?

Auteurs: Jessica F. Magidson, Alyson Listhaus, C. J. Seitz-Brown, Steven A. Safren, C. W. Lejuez, Stacey B. Daughters

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 2/2015

Abstract

Medication adherence is highly predictive of health outcomes across chronic conditions, particularly HIV/AIDS. Depression is consistently associated with worse adherence, yet few studies have sought to understand how depression relates to adherence. This study tested three components of behavioral depression theory—goal-directed activation, positive reinforcement, and environmental punishment—as potential indirect effects in the relation between depressive symptoms and medication nonadherence among low-income, predominantly African American substance users (n = 83). Medication nonadherence was assessed as frequency of doses missed across common reasons for nonadherence. Non-parametric bootstrapping was used to evaluate the indirect effects. Of the three intermediary variables, there was only an indirect effect of environmental punishment; depressive symptoms were associated with greater nonadherence through greater environmental punishment. Goal-directed activation and positive reinforcement were unrelated to adherence. Findings suggest the importance of environmental punishment in the relation between depression and medication adherence and may inform future intervention efforts for this population.

vorige artikel Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT

volgende artikel Mindfulness-based interventions for binge eating: a systematic review and meta-analysis

Airoldi, M., Zaccarelli, M., Bisi, L., Bini, T., Antinori, A., Mussini, C., et al. (2010). One-pill once-a-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Preference and Adherence, 4, 115.PubMedCentralPubMed

Asch, S. M., Kilbourne, A. M., Gifford, A. L., Burnam, M. A., Turner, B., Shapiro, M. F., et al. (2003). Underdiagnosis of depression in HIV. Journal of General Internal Medicine, 18, 450–460.CrossRefPubMedCentralPubMed

Aversa, S. L., & Kimberlin, C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29, 207–219.CrossRefPubMed

Benassi, V. A., Sweeney, P. D., & Dufour, C. L. (1988). Is there a relation between locus of control orientation and depression? Journal of Abnormal Psychology, 97, 357–367.CrossRefPubMed

Berger-Greenstein, J. A., Cuevas, C. A., Brady, S. M., Trezza, G., Richardson, M. A., & Keane, T. M. (2007). Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care and STDs, 21, 942–955.CrossRefPubMed

Binford, M. C., Kahana, S. Y., & Altice, F. L. (2012). A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports, 9, 287–312.CrossRefPubMed

Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721.CrossRefPubMed

Bogart, L. M., Wagner, G. J., Galvan, F. H., & Klein, D. J. (2010). Longitudinal relationships between antiretroviral treatment adherence and discrimination due to HIV-serostatus, race, and sexual orientation among African-American men with HIV. Annals of Behavioral Medicine, 40, 184–190.CrossRefPubMedCentralPubMed

Burack, J. H., Barrett, D. C., Stall, R. D., Chesney, M. A., Ekstrand, M. L., & Coates, T. J. (1993). Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association (JAMA), 270, 2568–2573.CrossRef

Carvalho, J. P., Gawrysiak, M. J., Hellmuth, J. C., McNulty, J. K., Magidson, J. F., Lejuez, C. W., et al. (2011). The Reward Probability Index (RPI): Design and validation of a scale measuring access to environmental reward. Behavior Therapy, 42, 249–262.CrossRefPubMed

Chander, G., Himelhoch, S., Fleishman, J. A., Hellinger, J., Gaist, P., Moore, R. D., et al. (2009). ART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care, 21, 655–663.CrossRefPubMedCentralPubMed

Chesney, M. (2003). Adherence to ART regimens. AIDS Patient Care and STDs, 17, 169–177.CrossRefPubMed

Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in the HIV clinical trials: The AACTG Adherence Instruments. AIDS Care, 12, 255–266.CrossRefPubMed

Crum, N. F., Riffenburgh, R. H., Wegner, S., Agan, B. K., Tasker, S. A., Spooner, K. M., et al. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes (JAIDS), 41, 194–200.CrossRef

Daughters, S. B., Magidson, J. F., Schuster, R. M., & Safren, S. A. (2010). ACT HEALTHY: A combined cognitive-behavioral depression and medication adherence treatment for HIV-infected substance users. Cognitive and Behavioral Practice, 17, 309–321.CrossRefPubMedCentralPubMed

DiIorio, C., McCarty, F., Depadilla, L., Resnicow, K., Holstad, M. M., Yeager, K., et al. (2009). Adherence to antiretroviral medication regimens: A test of a psychosocial model. AIDS and Behavior, 13, 10–22.CrossRefPubMedCentralPubMed

DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.CrossRefPubMed

Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. JAIDS, 18, 117–125.PubMed

Evans, S., Ferrando, S. J., Rabkin, J. B., & Fishman, B. (2000). Health locus of control, distress, and utilization of protease inhibitors among HIV-positive men. Journal of Psychosomatic Research, 49, 157–162.CrossRefPubMed

Ferster, C. B. (1973). A functional analysis of depression. American Psychologist, 28, 857–870.CrossRefPubMed

First, M. B., & Gibbon, M. (2004). Structured clinical interview for DSM-IV axis I disorders (SCID-I) and the structured clinical interview for DSM-IV Axis II disorders (SCID-II). In M. J. Hilsenroth, & D. L. Segal (Eds.), Comprehensive handbook of psychological assessment, Vol. 2: Personality assessment. Hoboken, NJ: Wiley.

Fritz, M. S., & MacKinnon, D. P. (2007). Required sample size to detect the mediated effect. Psychological Science, 18, 233–239.CrossRefPubMedCentralPubMed

García, D. O. P., Knobel, H., Carmona, A., Guelar, A., López-Colomés, J. L., & Caylà, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. JAIDS, 30, 105–110.

Gifford, A., Bormann, J., & Shively, M. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. JAIDS, 23, 386–395.PubMed

Gonzalez, J., Batchelder, A. W., Psaros, C., & Safren, S. (2011a). Depression and HIV/AIDS treatment nonadherence: A review and meta-analysis. JAIDS, 58, 181–187.PubMed

Gonzalez, J. S., Psaros, C., Batchelder, A., Applebaum, A., Newville, H., & Safren, S. (2011b). Clinician-assessed depression and ART adherence in HIV-infected individuals in methadone maintenance treatment. Annals of Behavioral Medicine, 42, 120–126.CrossRefPubMedCentralPubMed

Gore-Felton, C., & Koopman, C. (2008). Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosomatic Medicine, 70, 569–574.CrossRefPubMed

Hayes, A. F. (2009). Beyond Baron and Kenny: Statistical mediation analysis in the new millennium. Communication Monographs, 76, 408–420.CrossRef

Hicks, P. L., Mulvey, K. P., Chander, G., Fleishman, J. A., Josephs, J. S., Korthuis, P. T., et al. (2007). The impact of illicit drug use and substance abuse treatment on adherence to ART. AIDS Care, 19, 1134–1140.CrossRefPubMedCentralPubMed

Hiroto, D. S. (1974). Locus of control and learned helplessness. Journal of Experimental Psychology, 102, 187–193.CrossRef

Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDs, 13, 185–197.CrossRefPubMed

Horberg, M. A., Silverberg, M. J., Hurley, L. B., Towner, W. J., Klein, D. B., Bersoff-Matcha, S., et al. (2008). Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. JAIDS, 27, 384–390.

Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA, 285, 1466–1474.CrossRefPubMed

Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16, 199–211.CrossRefPubMed

Kalichman, S. C., Amaral, C. M., Swetzes, C., Jones, M., Macy, R., Kalichman, M. O., et al. (2009). A simple single-item rating scale to measure medication adherence: Further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care, 8, 367–374.CrossRefPubMed

Kanter, J. W., Mulick, P. S., Busch, A. M., Berlin, K. S., & Martell, C. R. (2007). The Behavioral Activation for Depression Scale (BADS): Psychometric properties and factor structure. Journal of Psychopathology and Behavioral Assessment, 29, 191–202.CrossRef

Kanter, J. W., Rusch, L. C., Busch, A. M., & Sedivy, S. K. (2009). Validation of the Behavioral Activation for Depression Scale (BADS) in a community sample with elevated depressive symptoms. Journal of Psychopathology and Behavioral Assessment, 31, 36–42.CrossRef

Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70, 539–545.CrossRefPubMed

Leserman, J., Petitto, J. M., Gu, H., Gaynes, B. N., Barroso, J., Golden, R. N., et al. (2002). Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychological Medicine, 32, 1059–1073.CrossRefPubMed

Lewinsohn, P. M. (1974). A behavioral approach to depression. In R. M. Friedman & M. M. Katz (Eds.), The psychology of depression: Contemporary theory and research. New York: Wiley.

Lewinsohn, P. M., & Graf, M. (1973). Pleasant activities and depression. Journal of Consulting and Clinical Psychology (JCCP), 41, 261–268.CrossRef

Lewinsohn, P. M., & Libet, J. (1972). Pleasant events, activity schedules, and depressions. Journal of Abnormal Psychology, 79, 291–295.CrossRefPubMed

Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., & Sanandaji, S. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.CrossRefPubMed

Magidson, J. F., Blashill, A. J., Safren, S. A., & Wagner, G. J. (in press). Depressive symptoms, lifestyle structure, and ART adherence among HIV-infected individuals: A longitudinal mediation analysis. AIDS and Behavior.

Magidson, J. F., Seitz-Brown, C. J., Safren, S. A., & Daughters, S. B. (2014). Implementing behavioral activation and Life-Steps for depression and HIV medication adherence in a community health center. Cognitive Behavioral Practice, 21, 386–403.

Maier, W., & Philipp, M. (1985). Improving the assessment of severity of depressive states: A reduction of the Hamilton Depression Rating Scale. Pharmacopsychiatry, 18, 114–115.CrossRef

Malebranche, D. J., Peterson, J. L., Fullilove, R. E., & Stackhouse, R. W. (2004). Race and sexual identity: Perceptions about medical culture and healthcare among Black men who have sex with men. Journal of the National Medical Association, 96, 97–107.PubMedCentralPubMed

Malta, M., Strathdee, S. A., Magnanini, M. M., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103, 1242–1257.CrossRefPubMed

Maxwell, S. E., & Cole, D. A. (2007). Bias in cross-sectional analyses of longitudinal mediation. Psychological Methods, 12, 23–44.CrossRefPubMed

McIntyre, R. S., Konarski, J. Z., Mancini, D. A., Fulton, K. A., Parikh, S. V., Grigoriadis, S., Grupp, L. A., & Kennedy, S. H. (2005). Measuring the severity of depression and remission in primary care: Validation of the HAMD-7 scale. Canadian Medical Association Journal, 173(11), 1327–1334.

Newcomb, M. D., & Harlow, L. L. (1986). Life events and substance use among adolescents: Mediating effects of perceived loss of control and meaninglessness in life. Journal of Personality and Social Psychology, 51, 564.CrossRefPubMed

O’Cleirigh, C., Ironson, G., & Smits, J. A. (2007). Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV? Behavior Therapist, 38, 314–323.CrossRef

Pablos-Méndez, A., Knirsch, C. A., Barr, R. G., Lerner, B. H., & Frieden, T. R. (1997). Nonadherence in tuberculosis treatment: Predictors and consequences in New York City. The American Journal of Medicine, 102, 164–170.CrossRefPubMed

Palmer, N. B., Salcedo, J., Miller, A. L., Winiarski, M., & Arno, P. (2003). Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care and STDs, 17, 635–644.CrossRefPubMed

Preacher, K. J., & Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, 36, 717–731.CrossRef

Preacher, K. J., & Hayes, A. F. (2008). Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods, 40, 879–891.CrossRefPubMed

Roberts, K. J. (2000). Barriers to and facilitators of HIV-positive patients’ adherence to antiretroviral treatment regimens. AIDS Patient Care and STDs, 14, 155–168.CrossRefPubMed

Rotter, J. B. (1966). Generalized expectancies for internal versus external control of reinforcement. Psychological Monographs: General and Applied, 80, 1–28.CrossRef

Rotter, J. B. (1975). Some problems and misconceptions related to the construct of internal versus external control of reinforcement. JCCP, 43, 56–67.

Ryan, G. W., & Wagner, G. J. (2003). Pill taking ‘routinization’: A critical factor to understanding episodic medication adherence. AIDS Care, 15, 795–806.CrossRefPubMed

Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial. JCCP, 80, 404–415.

Schlenk, E. A., & Hart, L. K. (1984). Relationship between health locus of control, health value, and social support and compliance of persons with diabetes mellitus. Diabetes Care, 7, 566–574.

Shah, S. S., McGowan, J. P., Smith, C., Blum, S., & Klein, R. S. (2002). Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clinical Infectious Diseases, 35, 1238–1243.CrossRefPubMed

Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29, 117–127.CrossRefPubMed

Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245.

Stanton, A. L. (1987). Determinants of adherence to medical regimens by hypertensive patients. Journal of Behavioral Medicine, 10, 377–394.CrossRefPubMed

Tabachnik, B. G., & Fidell, L. S. (2007). Using multivariate statistics. Boston: Pearson.

Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-, middle-, and high-income countries: A systematic review and meta-analysis. Current HIV/AIDS Reports, 11, 291–307.

Wagner, G. J., Goggin, K., Remien, R. H., Rosen, M. I., Simoni, J., Bangsberg, D. R., et al. (2011). A closer look at depression and its relationship to HIV antiretroviral adherence. Annals of Behavioral Medicine, 42, 352–360.CrossRefPubMedCentralPubMed

Wagner, G. J., & Ryan, G. W. (2004). Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDs, 18, 385–393.CrossRefPubMed

Walkup, J., Wei, W., Sambamoorthi, U., & Crystal, S. (2008). Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatric Quarterly, 79, 43–53.CrossRefPubMedCentralPubMed

Wallston, K. A., Wallston, B. S., & DeVellis, R. (1978). Development of the multidimensional health locus of control (MHLC) scales. Health Education and Behavior, 6, 160–170.CrossRef

Warner, E. A., Greene, G. S., Buchsbaum, M. S., Cooper, D. S., & Robinson, B. E. (1998). Diabetic ketoacidosis associated with cocaine use. Archives of Internal Medicine, 158, 1799.CrossRefPubMed

Titel: Can behavioral theory inform the understanding of depression and medication nonadherence among HIV-positive substance users?
Auteurs: Jessica F. Magidson
Alyson Listhaus
C. J. Seitz-Brown
Steven A. Safren
C. W. Lejuez
Stacey B. Daughters
Publicatiedatum: 01-04-2015
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 2/2015
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-014-9606-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2015

Meaning in life in chronic pain patients over time: associations with pain experience and psychological well-being

Shared versus specific features of psychological symptoms and cigarettes per day: structural relations and mediation by negative- and positive-reinforcement smoking

Stress, depression and medication nonadherence in diabetes: test of the exacerbating and buffering effects of family support

Rumination mediates the relationships between depressed mood and both sleep quality and self-reported health in young adults

Mindfulness-based interventions for binge eating: a systematic review and meta-analysis

The importance of perceived stress management skills for patients with prostate cancer in active surveillance